199 related articles for article (PubMed ID: 36123565)
1. The ERK5/NF-κB signaling pathway targets endometrial cancer proliferation and survival.
Diéguez-Martínez N; Espinosa-Gil S; Yoldi G; Megías-Roda E; Bolinaga-Ayala I; Viñas-Casas M; Gorgisen G; Domingo-Ortí I; Pérez-Montoyo H; Bayascas JR; Colas E; Dolcet X; Lizcano JM
Cell Mol Life Sci; 2022 Sep; 79(10):524. PubMed ID: 36123565
[TBL] [Abstract][Full Text] [Related]
2. Biochanin A protects against PM
Xue Z; Wang J; Yu W; Li D; Zhang Y; Wan F; Kou X
Food Funct; 2019 Nov; 10(11):7188-7203. PubMed ID: 31608342
[TBL] [Abstract][Full Text] [Related]
3. MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism.
Pereira DM; Simões AE; Gomes SE; Castro RE; Carvalho T; Rodrigues CM; Borralho PM
Oncotarget; 2016 Jun; 7(23):34322-40. PubMed ID: 27144434
[TBL] [Abstract][Full Text] [Related]
4. The MEK5-ERK5 Kinase Axis Controls Lipid Metabolism in Small-Cell Lung Cancer.
Cristea S; Coles GL; Hornburg D; Gershkovitz M; Arand J; Cao S; Sen T; Williamson SC; Kim JW; Drainas AP; He A; Cam LL; Byers LA; Snyder MP; Contrepois K; Sage J
Cancer Res; 2020 Mar; 80(6):1293-1303. PubMed ID: 31969375
[TBL] [Abstract][Full Text] [Related]
5. ERK5 and ERK2 cooperate to regulate NF-kappaB and cell transformation.
Pearson G; English JM; White MA; Cobb MH
J Biol Chem; 2001 Mar; 276(11):7927-31. PubMed ID: 11118448
[TBL] [Abstract][Full Text] [Related]
6. Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation.
Simões AE; Pereira DM; Gomes SE; Brito H; Carvalho T; French A; Castro RE; Steer CJ; Thibodeau SN; Rodrigues CM; Borralho PM
Cell Death Dis; 2015 Apr; 6(4):e1718. PubMed ID: 25855966
[TBL] [Abstract][Full Text] [Related]
7. Resistance to MAPK Inhibitors in Melanoma Involves Activation of the IGF1R-MEK5-Erk5 Pathway.
Benito-Jardón L; Díaz-Martínez M; Arellano-Sánchez N; Vaquero-Morales P; Esparís-Ogando A; Teixidó J
Cancer Res; 2019 May; 79(9):2244-2256. PubMed ID: 30833419
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological inhibition of the MEK5/ERK5 and PI3K/Akt signaling pathways synergistically reduces viability in triple-negative breast cancer.
Wright TD; Raybuck C; Bhatt A; Monlish D; Chakrabarty S; Wendekier K; Gartland N; Gupta M; Burow ME; Flaherty PT; Cavanaugh JE
J Cell Biochem; 2020 Feb; 121(2):1156-1168. PubMed ID: 31464004
[TBL] [Abstract][Full Text] [Related]
9. MEK5/ERK5 signaling mediates IL-4-induced M2 macrophage differentiation through regulation of c-Myc expression.
Luiz JPM; Toller-Kawahisa JE; Viacava PR; Nascimento DC; Pereira PT; Saraiva AL; Prado DS; LeBert M; Giurisato E; Tournier C; Cunha TM; Cunha FQ; Quesniaux V; Ryffel B; Alves-Filho JC
J Leukoc Biol; 2020 Oct; 108(4):1215-1223. PubMed ID: 32745297
[TBL] [Abstract][Full Text] [Related]
10. Etiopathogenic role of ERK5 signaling in sarcoma: prognostic and therapeutic implications.
Sánchez-Fdez A; Matilla-Almazán S; Del Carmen S; Abad M; Arconada-Luque E; Jiménez-Suárez J; Chinchilla-Tábora LM; Ruíz-Hidalgo MJ; Sánchez-Prieto R; Pandiella A; Esparís-Ogando A
Exp Mol Med; 2023 Jun; 55(6):1247-1257. PubMed ID: 37332046
[TBL] [Abstract][Full Text] [Related]
11. The WNK1-ERK5 route plays a pathophysiological role in ovarian cancer and limits therapeutic efficacy of trametinib.
Sánchez-Fdez A; Matilla-Almazán S; Montero JC; Del Carmen S; Abad M; García-Alonso S; Bhattacharya S; Calar K; de la Puente P; Ocaña A; Pandiella A; Esparís-Ogando A
Clin Transl Med; 2023 Apr; 13(4):e1217. PubMed ID: 37029785
[TBL] [Abstract][Full Text] [Related]
12. Genistein induces cell apoptosis in MDA-MB-231 breast cancer cells via the mitogen-activated protein kinase pathway.
Li Z; Li J; Mo B; Hu C; Liu H; Qi H; Wang X; Xu J
Toxicol In Vitro; 2008 Oct; 22(7):1749-53. PubMed ID: 18761399
[TBL] [Abstract][Full Text] [Related]
13. MEK5 and ERK5 are localized in the nuclei of resting as well as stimulated cells, while MEKK2 translocates from the cytosol to the nucleus upon stimulation.
Raviv Z; Kalie E; Seger R
J Cell Sci; 2004 Apr; 117(Pt 9):1773-84. PubMed ID: 15075238
[TBL] [Abstract][Full Text] [Related]
14. Natural angiogenesis inhibitor signals through Erk5 activation of peroxisome proliferator-activated receptor gamma (PPARgamma).
Biyashev D; Veliceasa D; Kwiatek A; Sutanto MM; Cohen RN; Volpert OV
J Biol Chem; 2010 Apr; 285(18):13517-24. PubMed ID: 20185831
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype.
Zhou C; Nitschke AM; Xiong W; Zhang Q; Tang Y; Bloch M; Elliott S; Zhu Y; Bazzone L; Yu D; Weldon CB; Schiff R; McLachlan JA; Beckman BS; Wiese TE; Nephew KP; Shan B; Burow ME; Wang G
Breast Cancer Res; 2008; 10(6):R105. PubMed ID: 19087274
[TBL] [Abstract][Full Text] [Related]
16. Targeting MEK5 impairs nonhomologous end-joining repair and sensitizes prostate cancer to DNA damaging agents.
Broustas CG; Duval AJ; Chaudhary KR; Friedman RA; Virk RK; Lieberman HB
Oncogene; 2020 Mar; 39(12):2467-2477. PubMed ID: 31980741
[TBL] [Abstract][Full Text] [Related]
17. HB-EGF induces cardiomyocyte hypertrophy via an ERK5-MEF2A-COX2 signaling pathway.
Lee KS; Park JH; Lim HJ; Park HY
Cell Signal; 2011 Jul; 23(7):1100-9. PubMed ID: 21244855
[TBL] [Abstract][Full Text] [Related]
18. BAFF activation of the ERK5 MAP kinase pathway regulates B cell survival.
Jacque E; Schweighoffer E; Tybulewicz VL; Ley SC
J Exp Med; 2015 Jun; 212(6):883-92. PubMed ID: 25987726
[TBL] [Abstract][Full Text] [Related]
19. Antagonizing binding of cell cycle and apoptosis regulatory protein 1 (CARP-1) to the NEMO/IKKγ protein enhances the anticancer effect of chemotherapy.
Venkatesh J; Sekhar SC; Cheriyan VT; Muthu M; Meister P; Levi E; Dzinic S; Gauld JW; Polin LA; Rishi AK
J Biol Chem; 2020 Mar; 295(11):3532-3552. PubMed ID: 32024692
[TBL] [Abstract][Full Text] [Related]
20. YAP promotes myogenic differentiation
Chen TH; Chen CY; Wen HC; Chang CC; Wang HD; Chuu CP; Chang CH
FASEB J; 2017 Jul; 31(7):2963-2972. PubMed ID: 28356344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
